vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and UNIFI INC (UFI). Click either name above to swap in a different company.
NATURES SUNSHINE PRODUCTS INC is the larger business by last-quarter revenue ($123.8M vs $121.4M, roughly 1.0× UNIFI INC). NATURES SUNSHINE PRODUCTS INC runs the higher net margin — 3.3% vs -8.0%, a 11.3% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs -12.6%). UNIFI INC produced more free cash flow last quarter ($24.2M vs $7.6M). Over the past eight quarters, NATURES SUNSHINE PRODUCTS INC's revenue compounded faster (5.6% CAGR vs -9.7%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Unifi Aviation, LLC is the largest aviation ground handling services in North America. Unifi was formed late 2018, after Delta Air Lines sold a stake of its subsidiary, DAL Global Services, to Argenbright Holdings. Unifi is jointly owned by Argenbright, who owns 51% of the company and Delta, who owns 49%.
NATR vs UFI — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $121.4M |
| Net Profit | $4.1M | $-9.7M |
| Gross Margin | 72.5% | 3.0% |
| Operating Margin | 4.3% | -6.0% |
| Net Margin | 3.3% | -8.0% |
| Revenue YoY | 4.7% | -12.6% |
| Net Profit YoY | 1379.4% | 14.8% |
| EPS (diluted) | $0.23 | $-0.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $121.4M | ||
| Q3 25 | $128.3M | $135.7M | ||
| Q2 25 | $114.8M | $138.5M | ||
| Q1 25 | $113.2M | $146.6M | ||
| Q4 24 | $118.2M | $138.9M | ||
| Q3 24 | $114.6M | $147.4M | ||
| Q2 24 | $110.6M | $157.5M | ||
| Q1 24 | $111.0M | $149.0M |
| Q4 25 | $4.1M | $-9.7M | ||
| Q3 25 | $5.3M | $-11.4M | ||
| Q2 25 | $5.3M | $15.5M | ||
| Q1 25 | $4.7M | $-16.8M | ||
| Q4 24 | $-321.0K | $-11.4M | ||
| Q3 24 | $4.3M | $-7.6M | ||
| Q2 24 | $1.3M | $-4.0M | ||
| Q1 24 | $2.3M | $-10.3M |
| Q4 25 | 72.5% | 3.0% | ||
| Q3 25 | 73.3% | 2.5% | ||
| Q2 25 | 71.7% | -0.8% | ||
| Q1 25 | 72.1% | -0.3% | ||
| Q4 24 | 72.0% | 0.4% | ||
| Q3 24 | 71.3% | 6.4% | ||
| Q2 24 | 71.4% | 6.9% | ||
| Q1 24 | 71.2% | 3.2% |
| Q4 25 | 4.3% | -6.0% | ||
| Q3 25 | 7.0% | -7.1% | ||
| Q2 25 | 3.7% | 10.9% | ||
| Q1 25 | 5.4% | -9.5% | ||
| Q4 24 | 3.8% | -5.4% | ||
| Q3 24 | 4.6% | -2.2% | ||
| Q2 24 | 5.1% | -0.5% | ||
| Q1 24 | 4.2% | -4.6% |
| Q4 25 | 3.3% | -8.0% | ||
| Q3 25 | 4.2% | -8.4% | ||
| Q2 25 | 4.6% | 11.2% | ||
| Q1 25 | 4.2% | -11.5% | ||
| Q4 24 | -0.3% | -8.2% | ||
| Q3 24 | 3.8% | -5.2% | ||
| Q2 24 | 1.2% | -2.5% | ||
| Q1 24 | 2.1% | -6.9% |
| Q4 25 | $0.23 | $-0.53 | ||
| Q3 25 | $0.30 | $-0.62 | ||
| Q2 25 | $0.28 | $0.85 | ||
| Q1 25 | $0.25 | $-0.92 | ||
| Q4 24 | $-0.02 | $-0.62 | ||
| Q3 24 | $0.23 | $-0.42 | ||
| Q2 24 | $0.07 | $-0.21 | ||
| Q1 24 | $0.12 | $-0.57 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $30.2M |
| Total DebtLower is stronger | — | $92.6M |
| Stockholders' EquityBook value | $161.6M | $230.0M |
| Total Assets | $261.1M | $382.9M |
| Debt / EquityLower = less leverage | — | 0.40× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $30.2M | ||
| Q3 25 | $95.6M | $20.6M | ||
| Q2 25 | $81.3M | $22.7M | ||
| Q1 25 | $86.5M | $16.3M | ||
| Q4 24 | $84.7M | $18.7M | ||
| Q3 24 | $78.7M | $13.7M | ||
| Q2 24 | $68.7M | $26.8M | ||
| Q1 24 | $77.8M | $27.7M |
| Q4 25 | — | $92.6M | ||
| Q3 25 | — | $107.5M | ||
| Q2 25 | — | $95.7M | ||
| Q1 25 | — | $127.9M | ||
| Q4 24 | — | $123.0M | ||
| Q3 24 | — | $119.3M | ||
| Q2 24 | — | $117.8M | ||
| Q1 24 | $2.1M | $116.1M |
| Q4 25 | $161.6M | $230.0M | ||
| Q3 25 | $166.7M | $241.1M | ||
| Q2 25 | $163.7M | $249.5M | ||
| Q1 25 | $167.1M | $228.4M | ||
| Q4 24 | $161.0M | $237.2M | ||
| Q3 24 | $162.6M | $259.7M | ||
| Q2 24 | $156.4M | $263.4M | ||
| Q1 24 | $159.7M | $277.8M |
| Q4 25 | $261.1M | $382.9M | ||
| Q3 25 | $264.8M | $424.6M | ||
| Q2 25 | $254.9M | $426.9M | ||
| Q1 25 | $252.7M | $446.5M | ||
| Q4 24 | $240.9M | $439.7M | ||
| Q3 24 | $245.3M | $467.0M | ||
| Q2 24 | $235.8M | $469.2M | ||
| Q1 24 | $247.3M | $482.6M |
| Q4 25 | — | 0.40× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.38× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.46× | ||
| Q2 24 | — | 0.45× | ||
| Q1 24 | 0.01× | 0.42× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $25.3M |
| Free Cash FlowOCF − Capex | $7.6M | $24.2M |
| FCF MarginFCF / Revenue | 6.1% | 20.0% |
| Capex IntensityCapex / Revenue | 1.9% | 0.9% |
| Cash ConversionOCF / Net Profit | 2.41× | — |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $1.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $25.3M | ||
| Q3 25 | $18.5M | $-8.9M | ||
| Q2 25 | $4.3M | $-1.3M | ||
| Q1 25 | $2.6M | $-5.0M | ||
| Q4 24 | $12.2M | $-2.2M | ||
| Q3 24 | $9.6M | $-12.8M | ||
| Q2 24 | $1.3M | $932.0K | ||
| Q1 24 | $2.2M | $-1.4M |
| Q4 25 | $7.6M | $24.2M | ||
| Q3 25 | $16.8M | $-10.9M | ||
| Q2 25 | $3.0M | $-3.9M | ||
| Q1 25 | $1.5M | $-8.0M | ||
| Q4 24 | $10.0M | $-5.1M | ||
| Q3 24 | $7.9M | $-14.9M | ||
| Q2 24 | $-2.0M | $-1.7M | ||
| Q1 24 | $-1.5M | $-3.9M |
| Q4 25 | 6.1% | 20.0% | ||
| Q3 25 | 13.1% | -8.1% | ||
| Q2 25 | 2.6% | -2.8% | ||
| Q1 25 | 1.3% | -5.4% | ||
| Q4 24 | 8.5% | -3.7% | ||
| Q3 24 | 6.9% | -10.1% | ||
| Q2 24 | -1.9% | -1.1% | ||
| Q1 24 | -1.4% | -2.6% |
| Q4 25 | 1.9% | 0.9% | ||
| Q3 25 | 1.3% | 1.5% | ||
| Q2 25 | 1.2% | 1.9% | ||
| Q1 25 | 1.0% | 2.0% | ||
| Q4 24 | 1.9% | 2.1% | ||
| Q3 24 | 1.5% | 1.4% | ||
| Q2 24 | 3.0% | 1.7% | ||
| Q1 24 | 3.3% | 1.7% |
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | — | ||
| Q2 25 | 0.81× | -0.09× | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
UFI
| Other | $67.8M | 56% |
| REPREVE Fiber | $34.3M | 28% |
| Export Sales From US Operations | $10.5M | 9% |
| All Other Foreign Countries | $8.8M | 7% |
